US2022332807A1PendingUtilityA1

Immunoglobulin variable domains

Assignee: ABLYNX NVPriority: May 16, 2014Filed: Mar 25, 2022Published: Oct 20, 2022
Est. expiryMay 16, 2034(~7.8 yrs left)· nominal 20-yr term from priority
C07K 16/00C07K 2317/31C07K 16/2875C07K 16/18C07K 2319/00C07K 2319/31C07K 2317/569C07K 16/2866C07K 16/4291A61P 37/02C07K 2317/567C07K 2317/35C07K 16/244C07K 2317/22C07K 16/30C07K 16/2863C07K 16/32C07K 2317/76C07K 16/241C07K 16/28C07K 16/42C07K 16/24C07K 2317/565C40B 40/10
83
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

VH domain, in which: (i) the amino acid residue at position 112 is one of K or Q; and/or (ii) the amino acid residue at position 89 is T; and/or (iii) the amino acid residue at position 89 is L and the amino acid residue at position 110 is one of K or Q; and (iv) in each of cases (i) to (iii), the amino acid at position 11 is preferably V; and in which said VH domain contains a C-terminal extension (X)n, in which n is 1 to 10, preferably 1 to 5, such as 1, 2, 3, 4 or 5 (and preferably 1 or 2, such as 1); and each X is an (preferably naturally occurring) amino acid residue that is independently chosen, and preferably independently chosen from the group consisting of alanine (A), glycine (G), valine (V), leucine (L) or isoleucine (I).

Claims

exact text as granted — not AI-modified
1 .- 72 . (canceled) 
     
     
         73 . A nucleic acid encoding a heavy chain ISVD or a polypeptide comprising said ISVD, wherein said ISVD comprises:
 (i) an amino acid K or Q at Kabat position 110; and   (ii) an amino acid V at Kabat position 11, an amino acid residue L at Kabat position 89, or a combination thereof.   
     
     
         74 . The nucleic acid of claim  72 , wherein the heavy chain ISVD comprises the amino acid V at position 11, optionally further comprising an amino acid at Kabat position 89 that is T, V, or L. 
     
     
         75 . The nucleic acid of claim  72 , wherein the heavy chain ISVD comprises the amino acid L at position 89, optionally further comprising an amino acid at Kabat position 11 that is L, E, K, V, or Y. 
     
     
         76 . The nucleic acid of claim  72 , wherein the heavy chain ISVD comprises the amino acid V at Kabat position 11 and the amino acid L at Kabat position 89. 
     
     
         77 . The nucleic acid of claim  72 , wherein the heavy chain ISVD comprises the amino acid K at Kabat position 110, the amino acid V at Kabat position 11 and the amino acid L at Kabat position 89. 
     
     
         78 . The nucleic acid of claim  72 , wherein the heavy chain ISVD comprises an amino acid selected from the group consisting of A and P at Kabat position 14. 
     
     
         79 . The nucleic acid of claim  72 , wherein the heavy chain ISVD comprises an amino acid selected from the group consisting of A and P at Kabat position 41. 
     
     
         80 . The nucleic acid of claim  72 , wherein the heavy chain ISVD comprises an amino acid selected from the group consisting of Q, L, R, P, E, K, S, T, M, A, and H at Kabat position 108. 
     
     
         81 . The nucleic acid of claim  72 , wherein the heavy chain ISVD comprises an amino acid selected from Q and L at Kabat position 108. 
     
     
         82 . The nucleic acid of claim  72 , wherein the heavy chain ISVD comprises an amino acid selected from the group consisting of S, T, A, L, P, F, E, and V at Kabat position 113. 
     
     
         83 . The nucleic acid of claim  72 , wherein the heavy chain ISVD comprises a C-terminal extension (X) n , in which n is 1 to 10, wherein each X is an independently chosen amino acid. 
     
     
         84 . The nucleic acid of  claim 83 , wherein each X is an amino acid independently chosen from the group consisting of A, G, V, L, and I. 
     
     
         85 . The nucleic acid of claim  72 , wherein the C-terminal end of the heavy-chain ISVD comprises an amino acid sequence selected from the group consisting of: VKVSS (SEQ ID NO: 95), VKVSS(X) n  (SEQ ID NO:97), VQVSS (SEQ ID NO: 96), VQVSS(X) n  (SEQ ID NO: 98), VZVZS (SEQ ID NO: 107), in which each amino acid residue Z is independently K or Q), and VZVZS(X) n  (SEQ ID NO:108), in which each amino acid residue Z is independently K or Q), in which n is 1 to 10, wherein each X is an independently chosen amino acid. 
     
     
         86 . The nucleic acid of  claim 85 , wherein each X is an amino acid independently chosen from the group consisting of A, G, V, L, and I. 
     
     
         87 . The nucleic acid of claim  72 , wherein the heavy chain ISVD is a VHH domain, a humanized VHH domain, or a camelized VH domain. 
     
     
         88 . A library comprising one or more nucleic acids according to claim  72 . 
     
     
         89 . The library of  claim 88 , wherein the library comprises at least 100 different sequences. 
     
     
         90 . A library of heavy chain ISVDs according to claim  72 . 
     
     
         91 . The library according to  claim 88 , which is an expression library. 
     
     
         92 . The library according to  claim 88 , which is a synthetic library. 
     
     
         93 . A method for producing a heavy chain ISVD comprising expressing the nucleic acid according to claim  72  in a suitable host organism.

Join the waitlist — get patent alerts

Track US2022332807A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.